Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis

Completed · Phase 2

Conditions studied: Chronic Myeloproliferative Disorders

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of chemotherapy followed by peripheral stem cell transplantation in treating patients who have myelofibrosis.

Key facts

Study ID

NCT00006367

Run by

Fred Hutchinson Cancer Center

Starts

2000-05-01

Expected to finish

2004-01-01

Last updated by the study team

2010-06-17

Who can join

Age: any, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Katmai Oncology Group — Anchorage, Alaska, United States
• H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States
• University of Illinois College of Medicine — Chicago, Illinois, United States
• Mayo Clinic Cancer Center — Rochester, Minnesota, United States
• Washington University Siteman Cancer Center — St Louis, Missouri, United States
• New York Presbyterian Hospital - Cornell Campus — New York, New York, United States
• Fred Hutchinson Cancer Research Center — Seattle, Washington, United States
• Hopital Saint-Louis — Paris, France
• Addenbrooke's NHS Trust — Cambridge, England, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.